COVID-19: Reimagining Biotech in 2021
An On-Demand Webinar Presented by BioCentury & McKinsey
ON-DEMAND RECORDING
RECORDED: July 8, 2021
As global biopharma leaders make contingency plans and build scenarios for a COVID-19 world, many are left to wonder: What will 2021 look like?
In Part 2 of this exclusive webinar series, BioCentury and McKinsey & Co. discussed key findings from a recent BioCentury industry survey about how 2021 will look different for biopharma companies. From budgeting, to clinical trials, to deals and financings, to supply chains, COVID-19 has fundamentally changed how the biopharma industry will operate in 2021, and beyond.
Following the initial discussion, BioCentury and McKinsey convened a panel of biotech C-Suite to discuss the survey findings and what industry should expect in 2021.
HOSTED BY
IN COLLABORATION WITH:
